These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 16123728)

  • 1. Cyclosporine preserves the anergic state of human T cells induced by costimulation blockade in vitro.
    Koenen HJ; Fasse E; Joosten I
    Transplantation; 2005 Aug; 80(4):522-9. PubMed ID: 16123728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of cell cycle progression by rapamycin induces T cell clonal anergy even in the presence of costimulation.
    Powell JD; Lerner CG; Schwartz RH
    J Immunol; 1999 Mar; 162(5):2775-84. PubMed ID: 10072524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human T cell activation by costimulatory signal-deficient allogeneic cells induces inducible costimulator-expressing anergic T cells with regulatory cell activity.
    Vermeiren J; Ceuppens JL; Van Ghelue M; Witters P; Bullens D; Mages HW; Kroczek RA; Van Gool SW
    J Immunol; 2004 May; 172(9):5371-8. PubMed ID: 15100277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of CD28-B7, but not CD40-CD154, prevents costimulation of allogeneic porcine and xenogeneic human anti-porcine T cell responses.
    Lee RS; Yamada K; Womer KL; Pillsbury EP; Allison KS; Marolewski AE; Geng D; Thall AD; Arn JS; Sachs DH; Sayegh MH; Madsen JC
    J Immunol; 2000 Mar; 164(6):3434-44. PubMed ID: 10706740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of CD86 and CD40 induces alloantigen-specific immunoregulatory T cells that remain anergic even after reversal of hyporesponsiveness.
    Koenen HJ; Joosten I
    Blood; 2000 May; 95(10):3153-61. PubMed ID: 10807782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blocking CD40 - CD154 and CD80/CD86 - CD28 interactions during primary allogeneic stimulation results in T cell anergy and high IL-10 production.
    Van Gool SW; Vermeiren J; Rafiq K; Lorr K; de Boer M; Ceuppens JL
    Eur J Immunol; 1999 Aug; 29(8):2367-75. PubMed ID: 10458748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human alloantigen-specific anergic cells induced by a combination of CTLA4-Ig and CsA maintain anti-leukemia and anti-viral cytotoxic responses.
    Comoli P; Locatelli F; Moretta A; Montagna D; Calcaterra V; Cometa A; Basso S; Zecca M; Maccario R
    Bone Marrow Transplant; 2001 Jun; 27(12):1263-73. PubMed ID: 11548844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cyclosporin A, rapamycin, and FK520 on peripheral T-cell deletion and anergy.
    Prud'homme GJ; Vanier LE; Bocarro DC; Ste-Croix H
    Cell Immunol; 1995 Aug; 164(1):47-56. PubMed ID: 7543371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-cell anergy induced by clonotype-specific antibodies: modulation of an autoreactive human T-cell clone in vitro.
    Steenbakkers PG; Boots AM; Rijnders AW
    Immunology; 1999 Apr; 96(4):586-94. PubMed ID: 10233745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human T cell responses to human and porcine endothelial cells are highly sensitive to cyclosporin A and FK506 in vitro.
    Batten P; McCormack AM; Page CS; Yacoub MH; Rose ML
    Transplantation; 1999 Nov; 68(10):1552-60. PubMed ID: 10589954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD80, CD86 and CD40 provide accessory signals in a multiple-step T-cell activation model.
    Van Gool SW; Vandenberghe P; de Boer M; Ceuppens JL
    Immunol Rev; 1996 Oct; 153():47-83. PubMed ID: 9010719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of CD47 in the induction of human naive T cell anergy.
    Avice MN; Rubio M; Sergerie M; Delespesse G; Sarfati M
    J Immunol; 2001 Sep; 167(5):2459-68. PubMed ID: 11509584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD40 stimulation in vivo does not inhibit CD4+ T cell tolerance to soluble antigens.
    Sun J; Van Houten N
    Immunol Lett; 2002 Nov; 84(2):125-32. PubMed ID: 12270549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed cytokine mRNA expression kinetics after T-lymphocyte costimulation: a quantitative measure of the efficacy of cyclosporin A-based immunosuppression.
    Härtel C; Fricke L; Schumacher N; Kirchner H; Müller-Steinhardt M
    Clin Chem; 2002 Dec; 48(12):2225-31. PubMed ID: 12446480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anergic T cells generated in vitro suppress rejection response to islet allografts.
    Luo Z; Gotoh M; Grochowiecki T; Tanaka T; Kimura F; Kawashima H; Yagita H; Okumura K; Miyasaka M
    Transplantation; 2000 May; 69(10):2144-8. PubMed ID: 10852614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel bispecific antihuman CD40/CD86 fusion protein with t-cell tolerizing potential.
    Koenen HJ; den Hartog MT; Heerkens S; Fasse E; Ortiz-Buijsse A; van Neerven RJ; Simons PJ; Joosten I; Boon L
    Transplantation; 2004 Nov; 78(10):1429-38. PubMed ID: 15599306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of B7-blocking agent and/or CsA on induction of platelet-specific T-cell anergy in chronic autoimmune thrombocytopenic purpura.
    Peng J; Liu C; Liu D; Ren C; Li W; Wang Z; Xing N; Xu C; Chen X; Ji C; Zhang M; Hou M
    Blood; 2003 Apr; 101(7):2721-6. PubMed ID: 12446456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alloantigen-induced human lymphocytes rendered nonresponsive by a combination of anti-CD80 monoclonal antibodies and cyclosporin-A suppress mixed lymphocyte reaction in vitro.
    Comoli P; Montagna D; Moretta A; Zecca M; Locatelli F; Maccario R
    J Immunol; 1995 Dec; 155(12):5506-11. PubMed ID: 7499831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B7-H1 (programmed death-1 ligand) on dendritic cells is involved in the induction and maintenance of T cell anergy.
    Selenko-Gebauer N; Majdic O; Szekeres A; Höfler G; Guthann E; Korthäuer U; Zlabinger G; Steinberger P; Pickl WF; Stockinger H; Knapp W; Stöckl J
    J Immunol; 2003 Apr; 170(7):3637-44. PubMed ID: 12646628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superior T-cell suppression by rapamycin and FK506 over rapamycin and cyclosporine A because of abrogated cytotoxic T-lymphocyte induction, impaired memory responses, and persistent apoptosis.
    Koenen HJ; Michielsen EC; Verstappen J; Fasse E; Joosten I
    Transplantation; 2003 May; 75(9):1581-90. PubMed ID: 12792519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.